{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:35:02Z","timestamp":1784180102799,"version":"3.55.0"},"reference-count":96,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T00:00:00Z","timestamp":1689552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Science and Technology Council","award":["NSTC111-2314-B-038-017"],"award-info":[{"award-number":["NSTC111-2314-B-038-017"]}]},{"name":"National Science and Technology Council","award":["MOST111-2314-B-038-122"],"award-info":[{"award-number":["MOST111-2314-B-038-122"]}]},{"name":"National Science and Technology Council","award":["SKH-TMU-112-02"],"award-info":[{"award-number":["SKH-TMU-112-02"]}]},{"name":"National Science and Technology Council","award":["NSTC 111-2314-B-038-098"],"award-info":[{"award-number":["NSTC 111-2314-B-038-098"]}]},{"name":"National Science and Technology Council","award":["NSTC111-2314-B-038-142"],"award-info":[{"award-number":["NSTC111-2314-B-038-142"]}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSTC111-2314-B-038-017"],"award-info":[{"award-number":["NSTC111-2314-B-038-017"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["MOST111-2314-B-038-122"],"award-info":[{"award-number":["MOST111-2314-B-038-122"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["SKH-TMU-112-02"],"award-info":[{"award-number":["SKH-TMU-112-02"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSTC 111-2314-B-038-098"],"award-info":[{"award-number":["NSTC 111-2314-B-038-098"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology","doi-asserted-by":"publisher","award":["NSTC111-2314-B-038-142"],"award-info":[{"award-number":["NSTC111-2314-B-038-142"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["NSTC111-2314-B-038-017"],"award-info":[{"award-number":["NSTC111-2314-B-038-017"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["MOST111-2314-B-038-122"],"award-info":[{"award-number":["MOST111-2314-B-038-122"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["SKH-TMU-112-02"],"award-info":[{"award-number":["SKH-TMU-112-02"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["NSTC 111-2314-B-038-098"],"award-info":[{"award-number":["NSTC 111-2314-B-038-098"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004319","name":"Shin Kong Wu Ho-Su Memorial Hospital","doi-asserted-by":"publisher","award":["NSTC111-2314-B-038-142"],"award-info":[{"award-number":["NSTC111-2314-B-038-142"]}],"id":[{"id":"10.13039\/501100004319","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC111-2314-B-038-017"],"award-info":[{"award-number":["NSTC111-2314-B-038-017"]}]},{"name":"National Science and Technology Council, Taiwan","award":["MOST111-2314-B-038-122"],"award-info":[{"award-number":["MOST111-2314-B-038-122"]}]},{"name":"National Science and Technology Council, Taiwan","award":["SKH-TMU-112-02"],"award-info":[{"award-number":["SKH-TMU-112-02"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC 111-2314-B-038-098"],"award-info":[{"award-number":["NSTC 111-2314-B-038-098"]}]},{"name":"National Science and Technology Council, Taiwan","award":["NSTC111-2314-B-038-142"],"award-info":[{"award-number":["NSTC111-2314-B-038-142"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Tumor angiogenesis and lymphangiogenesis pathways have been identified as important therapeutic targets in non-small cell lung cancer (NSCLC). Bevacizumab, which is a monoclonal antibody, was the initial inhibitor of angiogenesis and lymphangiogenesis that received approval for use in the treatment of advanced non-small cell lung cancer (NSCLC) in combination with chemotherapy. Despite its usage, patients may still develop resistance to the treatment, which can be attributed to various histological subtypes and the initiation of treatment at advanced stages of cancer. Due to their better specificity, selectivity, and safety compared to chemotherapy, small molecules have been approved for treating advanced NSCLC. Based on the development of multiple small-molecule antiangiogenic drugs either in house and abroad or in other laboratories to treat NSCLC, we used a quinoline-derived small molecule\u2014HN-N07\u2014as a potential target drug for NSCLC. Accordingly, we used computational simulation tools and evaluated the drug-likeness properties of HN-N07. Moreover, we identified target genes, resulting in the discovery of the target BIRC5\/HIF1A\/FLT4 pro-angiogenic genes. Furthermore, we used in silico molecular docking analysis to determine whether HN-N07 could potentially inhibit BIRC5\/HIF1A\/FLT4. Interestingly, the results of docking HN-N07 with the BIRC5, FLT4, and HIF1A oncogenes revealed unique binding affinities, which were significantly higher than those of standard inhibitors. In summary, these results indicate that HN-N07 shows promise as a potential inhibitor of oncogenic signaling pathways in NSCLC. Ongoing studies that involve in vitro experiments and in vivo investigations using tumor-bearing mice are in progress, aiming to evaluate the therapeutic effectiveness of the HN-N07 small molecule.<\/jats:p>","DOI":"10.3390\/biomedicines11072011","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T01:35:16Z","timestamp":1689644116000},"page":"2011","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In Silico Evaluation of HN-N07 Small Molecule as an Inhibitor of Angiogenesis and Lymphangiogenesis Oncogenic Signatures in Non-Small Cell Lung Cancer"],"prefix":"10.3390","volume":"11","author":[{"given":"Lung-Ching","family":"Chen","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 11101, Taiwan"},{"name":"School of Medicine, Fu Jen Catholic University, New Taipei 24205, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2076-9768","authenticated-orcid":false,"given":"Ntlotlang","family":"Mokgautsi","sequence":"additional","affiliation":[{"name":"PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan"},{"name":"Graduate Institute for Cancer Biology & Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Cheng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"School of Post-Baccalaureate Chinese Medicine, College of Chinese Medicine, China Medical University, Taichung 40402, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0178-6530","authenticated-orcid":false,"given":"Alexander T. H.","family":"Wu","sequence":"additional","affiliation":[{"name":"The PhD Program of Translational Medicine, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Clinical Research Center, Taipei Medical University Hospital, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"TMU Research Center of Cancer Translational Medicine, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6193-5182","authenticated-orcid":false,"given":"Hsu-Shan","family":"Huang","sequence":"additional","affiliation":[{"name":"PhD Program for Cancer Molecular Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University and Academia Sinica, Taipei 11031, Taiwan"},{"name":"Graduate Institute for Cancer Biology & Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taipei 11031, Taiwan"},{"name":"Graduate Institute of Medical Sciences, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"School of Pharmacy, National Defense Medical Center, Taipei 11490, Taiwan"},{"name":"PhD Program in Drug Discovery and Development Industry, College of Pharmacy, Taipei Medical University, Taipei 11031, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13045-020-00881-7","article-title":"Emerging therapeutic agents for advanced non-small cell lung cancer","volume":"13","author":"Chen","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Chen, D., Zhang, L.Q., Huang, J.F., Liu, K., Chuai, Z.R., Yang, Z., Wang, Y.X., Shi, D.C., Liu, Q., and Huang, Q. (2014). BRAF mutations in patients with non-small cell lung cancer: A systematic review and meta-analysis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0101354"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0140-6736(09)61497-5","article-title":"Maintenance pemetrexed plus best supportive care versus placebo plus best supportive care for non-small-cell lung cancer: A randomised, double-blind, phase 3 study","volume":"374","author":"Ciuleanu","year":"2009","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1164\/rccm.200504-531OE","article-title":"One hundred years of lung cancer","volume":"172","author":"Spiro","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1158\/1078-0432.CCR-18-1538","article-title":"Immunotherapy in Non-Small Cell Lung Cancer: Facts and Hopes","volume":"25","author":"Doroshow","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1470-2045(12)70063-3","article-title":"Maintenance therapy with pemetrexed plus best supportive care versus placebo plus best supportive care after induction therapy with pemetrexed plus cisplatin for advanced non-squamous non-small-cell lung cancer (PARAMOUNT): A double-blind, phase 3, randomised controlled trial","volume":"13","author":"Dediu","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","article-title":"Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment","volume":"94","author":"Duma","year":"2019","journal-title":"Mayo Clin. Proc."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Non-small Cell Lung Cancer Collaborative Group (1995). Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group. BMJ, 311, 899\u2013909.","DOI":"10.1136\/bmj.311.7010.899"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s41419-018-0733-4","article-title":"Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation","volume":"9","author":"Li","year":"2018","journal-title":"Cell Death Dis."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"111633","DOI":"10.1016\/j.ejmech.2019.111633","article-title":"Discovery, structural insight, and bioactivities of BY27 as a selective inhibitor of the second bromodomains of BET proteins","volume":"182","author":"Chen","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"jcs223826","DOI":"10.1242\/jcs.223826","article-title":"Survivin at a glance","volume":"132","author":"Wheatley","year":"2019","journal-title":"J. Cell Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4103\/0971-5916.159250","article-title":"Survivin: A molecular biomarker in cancer","volume":"141","author":"Jaiswal","year":"2015","journal-title":"Indian J. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.7150\/jca.69236","article-title":"BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma","volume":"13","author":"Ma","year":"2022","journal-title":"J. Cancer"},{"key":"ref_14","first-page":"4507","article-title":"The apoptosis inhibitor protein survivin induces tumor-specific CD8+ and CD4+ T cells in colorectal cancer patients","volume":"63","author":"Casati","year":"2003","journal-title":"Cancer Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s00262-012-1266-9","article-title":"Survivin-specific T-cell reactivity correlates with tumor response and patient survival: A phase-II peptide vaccination trial in metastatic melanoma","volume":"61","author":"Becker","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ctrv.2013.02.002","article-title":"Treat cancers by targeting survivin: Just a dream or future reality?","volume":"39","author":"Coumar","year":"2013","journal-title":"Cancer Treat. Rev."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1186\/s13046-019-1362-1","article-title":"Cancer therapeutics using survivin BIRC5 as a target: What can we do after over two decades of study?","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/21655979.2016.1252879","article-title":"Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysis","volume":"8","author":"Fan","year":"2017","journal-title":"Bioengineered"},{"key":"ref_21","first-page":"57","article-title":"Localization and upregulation of survivin in cancer health disparities: A clinical perspective","volume":"9","author":"Khan","year":"2015","journal-title":"Biologics"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"F\u00e4ldt Beding, A., Larsson, P., Helou, K., Einbeigi, Z., and Parris, T.Z. (2022). Pan-cancer analysis identifies BIRC5 as a prognostic biomarker. BMC Cancer, 22.","DOI":"10.1186\/s12885-022-09371-0"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.canlet.2006.03.007","article-title":"Structural, functional and therapeutic biology of survivin","volume":"244","author":"Sah","year":"2006","journal-title":"Cancer Lett."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.1158\/1078-0432.CCR-08-0746","article-title":"Survivin: Key regulator of mitosis and apoptosis and novel target for cancer therapeutics","volume":"14","author":"Mita","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"9177545","DOI":"10.1155\/2022\/9177545","article-title":"Association of BIRC5 Gene Polymorphism with the Collateral Circulation and Severity of Large Artery Atherosclerotic Stroke","volume":"2022","author":"Huang","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"13476","DOI":"10.1074\/jbc.M113.527556","article-title":"Role of c-Met\/phosphatidylinositol 3-kinase (PI3k)\/Akt signaling in hepatocyte growth factor (HGF)-mediated lamellipodia formation, reactive oxygen species (ROS) generation, and motility of lung endothelial cells","volume":"289","author":"Usatyuk","year":"2014","journal-title":"J. Biol. Chem."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"213","DOI":"10.2147\/vhrm.2006.2.3.213","article-title":"Angiogenesis in cancer","volume":"2","author":"Nishida","year":"2006","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1871530315666150316121956","article-title":"VEGF-VEGFR System as a Target for Suppressing Inflammation and other Diseases","volume":"15","author":"Shibuya","year":"2015","journal-title":"Endocr. Metab. Immune Disord. Drug Targets"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2174\/1570161115666170105124038","article-title":"Vascular Endothelial Growth Factor (VEGF) Signaling in Tumour Vascularization: Potential and Challenges","volume":"15","author":"Siveen","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1242\/jcs.113.1.59","article-title":"Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: Auto-paracrine role during endochondral bone formation","volume":"113","author":"Carlevaro","year":"2000","journal-title":"J. Cell Sci."},{"key":"ref_31","first-page":"455","article-title":"Vascular endothelial growth factor (VEGF)\u2014Key factor in normal and pathological angiogenesis","volume":"59","author":"Melincovici","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"ref_32","first-page":"5227","article-title":"Immunohistochemical expression and prognostic significance of HIF-1\u03b1 and VEGF-C in neuroendocrine breast cancer","volume":"32","author":"Marton","year":"2012","journal-title":"Anticancer Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1097\/JTO.0b013e318265b4df","article-title":"Endobronchial ultrasound doppler image features correlate with mRNA expression of HIF1-\u03b1 and VEGF-C in patients with non-small-cell lung cancer","volume":"7","author":"Nakajima","year":"2012","journal-title":"J. Thorac. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1002\/(SICI)1097-0142(19961115)78:10<2111::AID-CNCR11>3.0.CO;2-1","article-title":"Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival","volume":"78","author":"Chevret","year":"1996","journal-title":"Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jso.21228","article-title":"Vascular endothelial growth factor-C and -D expression correlates with lymph node micrometastasis in pN0 early gastric cancer","volume":"99","author":"Arigami","year":"2009","journal-title":"J. Surg. Oncol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bjc.6690356","article-title":"Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis","volume":"80","author":"Tsurusaki","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.leu.2400722","article-title":"Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia","volume":"11","author":"Fielder","year":"1997","journal-title":"Leukemia"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1080\/15548627.2021.1985338","article-title":"FLT4\/VEGFR3 activates AMPK to coordinate glycometabolic reprogramming with autophagy and inflammasome activation for bacterial elimination","volume":"18","author":"Ma","year":"2022","journal-title":"Autophagy"},{"key":"ref_39","first-page":"203","article-title":"Regulation of angiogenesis via vascular endothelial growth factor receptors","volume":"60","author":"Veikkola","year":"2000","journal-title":"Cancer Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3566","DOI":"10.1073\/pnas.92.8.3566","article-title":"Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development","volume":"92","author":"Kaipainen","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0002-9440(10)65285-6","article-title":"Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries: Podoplanin as a specific marker for lymphatic endothelium","volume":"154","author":"Soleiman","year":"1999","journal-title":"Am. J. Pathol."},{"key":"ref_42","first-page":"746","article-title":"FLT4, a novel class III receptor tyrosine kinase in chromosome 5q33-qter","volume":"52","author":"Aprelikova","year":"1992","journal-title":"Cancer Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/jemt.1160","article-title":"Lymphatic function, lymphangiogenesis, and cancer metastasis","volume":"55","author":"Swartz","year":"2001","journal-title":"Microsc. Res. Tech."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.yexcr.2005.11.008","article-title":"VEGF function in vascular pathogenesis","volume":"312","author":"Ng","year":"2006","journal-title":"Exp. Cell Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1042\/CS20040370","article-title":"The vascular endothelial growth factor (VEGF)\/VEGF receptor system and its role under physiological and pathological conditions","volume":"109","author":"Takahashi","year":"2005","journal-title":"Clin. Sci."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrm1911","article-title":"VEGF receptor signalling\u2014In control of vascular function","volume":"7","author":"Olsson","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.lungcan.2004.03.006","article-title":"Human small cell lung cancer cells express functional VEGF receptors, VEGFR-2 and VEGFR-3","volume":"46","author":"Tanno","year":"2004","journal-title":"Lung Cancer"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/84651","article-title":"Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3","volume":"7","author":"Jussila","year":"2001","journal-title":"Nat. Med."},{"key":"ref_49","first-page":"3003","article-title":"Expression of hypoxia-inducible factor (HIF-1alpha), VEGF-C and VEGF-D in non-invasive and invasive breast ductal carcinomas","volume":"25","author":"Okada","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"e000543","DOI":"10.1136\/jitc-2020-000543","article-title":"TFEB is a master regulator of tumor-associated macrophages in breast cancer","volume":"8","author":"Li","year":"2020","journal-title":"J. Immunother. Cancer"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1089\/ars.2019.7935","article-title":"Targeting Hypoxia-Inducible Factor-1-Mediated Metastasis for Cancer Therapy","volume":"34","author":"Ma","year":"2021","journal-title":"Antioxid. Redox Signal."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2018.07.034","article-title":"Molecular targeted therapy: Treating cancer with specificity","volume":"834","author":"Lee","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpb.2015.03.018","article-title":"Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy","volume":"93","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-021-00572-w","article-title":"Small molecules in targeted cancer therapy: Advances, challenges, and future perspectives","volume":"6","author":"Zhong","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"4386","DOI":"10.2174\/09298673113209990170","article-title":"Medicinal chemistry of quinolines as emerging anti-inflammatory agents: An overview","volume":"20","author":"Mukherjee","year":"2013","journal-title":"Curr. Med. Chem."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/acs.jcim.5b00713","article-title":"Assessing the Growth of Bioactive Compounds and Scaffolds over Time: Implications for Lead Discovery and Scaffold Hopping","volume":"56","author":"Jasial","year":"2016","journal-title":"J. Chem. Inf. Model."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1089\/ars.2017.7487","article-title":"Anticancer Thiosemicarbazones: Chemical Properties, Interaction with Iron Metabolism, and Resistance Development","volume":"30","author":"Heffeter","year":"2019","journal-title":"Antioxid. Redox Signal"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"105814","DOI":"10.1016\/j.compbiomed.2022.105814","article-title":"Identification of a novel immune-inflammatory signature of COVID-19 infections, and evaluation of pharmacokinetics and therapeutic potential of RXn-02, a novel small-molecule derivative of quinolone","volume":"148","author":"Lawal","year":"2022","journal-title":"Comput. Biol. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s12017-009-8058-1","article-title":"Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons","volume":"11","author":"Liu","year":"2009","journal-title":"Neuromol. Med."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ejmech.2011.10.059","article-title":"Synthesis, antiproliferative activities and telomerase inhibition evaluation of novel asymmetrical 1,2-disubstituted amidoanthraquinone derivatives","volume":"47","author":"Lee","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1016\/j.biocel.2011.08.006","article-title":"Different roles of p53 in the regulation of DNA damage caused by 1,2-heteroannelated anthraquinones and doxorubicin","volume":"43","author":"Chang","year":"2011","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Bartha, \u00c1., and Gy\u0151rffy, B. (2021). TNMplot.com: A Web Tool for the Comparison of Gene Expression in Normal, Tumor and Metastatic Tissues. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22052622"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/nar\/gkg034","article-title":"STRING: A database of predicted functional associations between proteins","volume":"31","author":"Huynen","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ijc.33283","article-title":"muTarget: A platform linking gene expression changes and mutation status in solid tumors","volume":"148","author":"Nagy","year":"2021","journal-title":"Int. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.it.2016.12.001","article-title":"Single-Cell Genomics: Approaches and Utility in Immunology","volume":"38","author":"Neu","year":"2017","journal-title":"Trends Immunol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.cell.2017.11.011","article-title":"Single-Cell Genomics: A Stepping Stone for Future Immunology Discoveries","volume":"172","author":"Giladi","year":"2018","journal-title":"Cell"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"D1420","DOI":"10.1093\/nar\/gkaa1020","article-title":"TISCH: A comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment","volume":"49","author":"Sun","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: An integrated repository portal for tumor-immune system interactions","volume":"35","author":"Ru","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/978-1-4939-7493-1_12","article-title":"Profiling Tumor Infiltrating Immune Cells with CIBERSORT","volume":"1711","author":"Chen","year":"2018","journal-title":"Methods Mol. Biol."},{"key":"ref_71","doi-asserted-by":"crossref","unstructured":"Mokgautsi, N., Wang, Y.C., Lawal, B., Khedkar, H., Sumitra, M.R., Wu, A.T.H., and Huang, H.S. (2021). Network Pharmacological Analysis through a Bioinformatics Approach of Novel NSC765600 and NSC765691 Compounds as Potential Inhibitors of CCND1\/CDK4\/PLK1\/CD44 in Cancer Types. Cancers, 13.","DOI":"10.3390\/cancers13112523"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"W32","DOI":"10.1093\/nar\/gku293","article-title":"SwissTargetPrediction: A web server for target prediction of bioactive small molecules","volume":"42","author":"Gfeller","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Ali, A.A., Lee, Y.R., Chen, T.C., Chen, C.L., Lee, C.C., Shiau, C.Y., Chiang, C.H., and Huang, H.S. (2016). Novel Anthra[1,2-c][1,2,5]Thiadiazole-6,11-Diones as Promising Anticancer Lead Compounds: Biological Evaluation, Characterization & Molecular Targets Determination. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0154278"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Mokgautsi, N., Kuo, Y.C., Tang, S.L., Liu, F.C., Chen, S.J., Wu, A.T.H., and Huang, H.S. (2022). Anticancer Activities of 9-chloro-6-(piperazin-1-yl)-11H-indeno[1,2-c] quinolin-11-one (SJ10) in Glioblastoma Multiforme (GBM) Chemoradioresistant Cell Cycle-Related Oncogenic Signatures. Cancers, 14.","DOI":"10.3390\/cancers14010262"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Lawal, B., Liu, Y.L., Mokgautsi, N., Khedkar, H., Sumitra, M.R., Wu, A.T.H., and Huang, H.S. (2021). Pharmacoinformatics and Preclinical Studies of NSC765690 and NSC765599, Potential STAT3\/CDK2\/4\/6 Inhibitors with Antitumor Activities against NCI60 Human Tumor Cell Lines. Biomedicines, 9.","DOI":"10.3390\/biomedicines9010092"},{"key":"ref_76","first-page":"5","article-title":"Adenocarcinoma classification: Patterns and prognosis","volume":"110","author":"Kuhn","year":"2018","journal-title":"Pathologica"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/978-1-0716-0301-7_7","article-title":"Profiling Cell Type Abundance and Expression in Bulk Tissues with CIBERSORTx","volume":"2117","author":"Steen","year":"2020","journal-title":"Methods Mol. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.2174\/138955709791012247","article-title":"Biological activities of quinoline derivatives","volume":"9","author":"Kumar","year":"2009","journal-title":"Mini Rev. Med. Chem."},{"key":"ref_79","first-page":"189","article-title":"Lung cancer: Biology and treatment options","volume":"1856","author":"Hassan","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.semcancer.2017.11.019","article-title":"Current WHO guidelines and the critical role of immunohistochemical markers in the subclassification of non-small cell lung carcinoma (NSCLC): Moving from targeted therapy to immunotherapy","volume":"52","author":"Osmani","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41416-020-01069-z","article-title":"The current treatment landscape in the UK for stage III NSCLC","volume":"123","author":"Evison","year":"2020","journal-title":"Br. J. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00408-020-00407-5","article-title":"Update 2020: Management of Non-Small Cell Lung Cancer","volume":"198","author":"Alexander","year":"2020","journal-title":"Lung"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1001\/jamaoncol.2018.3039","article-title":"Effect of Anlotinib as a Third-Line or Further Treatment on Overall Survival of Patients with Advanced Non-Small Cell Lung Cancer: The ALTER 0303 Phase 3 Randomized Clinical Trial","volume":"4","author":"Han","year":"2018","journal-title":"JAMA Oncol."},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Manzo, A., Montanino, A., Carillio, G., Costanzo, R., Sandomenico, C., Normanno, N., Piccirillo, M.C., Daniele, G., Perrone, F., and Rocco, G. (2017). Angiogenesis Inhibitors in NSCLC. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102021"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1038\/nrc909","article-title":"VEGF and the quest for tumour angiogenesis factors","volume":"2","author":"Ferrara","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.critrevonc.2012.02.004","article-title":"Multitargeted anti-angiogenic agents and NSCLC: Clinical update and future directions","volume":"84","author":"Ellis","year":"2012","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12943-015-0467-1","article-title":"The twisted survivin connection to angiogenesis","volume":"14","author":"Sanhueza","year":"2015","journal-title":"Mol. Cancer"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s12032-013-0775-5","article-title":"Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis","volume":"31","author":"Chen","year":"2014","journal-title":"Med. Oncol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1038\/sj.gt.3302280","article-title":"Tumor-specific gene expression using the survivin promoter is further increased by hypoxia","volume":"11","author":"Yang","year":"2004","journal-title":"Gene Ther."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1756-9966-28-29","article-title":"Effect of hypoxia-inducible factor-1alpha on transcription of survivin in non-small cell lung cancer","volume":"28","author":"Chen","year":"2009","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"25903","DOI":"10.1074\/jbc.M603414200","article-title":"Cross-talk between epidermal growth factor receptor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression","volume":"281","author":"Peng","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"7071","DOI":"10.18632\/oncotarget.27378","article-title":"A close relationship between HIF-1\u03b1 expression and bone metastases in advanced NSCLC, a retrospective analysis","volume":"10","author":"Pezzuto","year":"2019","journal-title":"Oncotarget"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"117384","DOI":"10.1016\/j.bmc.2023.117384","article-title":"Discovery of novel hypoxia-activated, nitroimidazole constructed multi-target kinase inhibitors on the basis of AZD9291 for the treatment of human lung cancer","volume":"91","author":"Jia","year":"2023","journal-title":"Bioorg. Med. Chem."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41573-020-0082-8","article-title":"Kinase inhibition in autoimmunity and inflammation","volume":"20","author":"Zarrin","year":"2021","journal-title":"Nat. Rev. Drug Discov."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2011\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:13:25Z","timestamp":1760127205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/11\/7\/2011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,17]]},"references-count":96,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2023,7]]}},"alternative-id":["biomedicines11072011"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines11072011","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,17]]}}}